
Danaher Corporation DHR
€ 163.62
-0.12%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation EV/EBITDA 2011-2026 | DHR
EV/EBITDA Jährlich Danaher Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 20.1 | 37.8 | 27.5 | 18.1 | 18.9 | 17.2 | 12.8 | 10.1 | 9.62 | 8.95 | 9.93 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 37.8 | 8.95 | 17.4 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
27.4 | $ 112.78 | 0.68 % | $ 34.3 B | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.13 | - | $ 4.89 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.31 | -0.12 % | $ 493 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 74.22 | -1.99 % | $ 5.01 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 457.05 | 0.03 % | $ 13.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 242.53 | 0.28 % | $ 25.6 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.59 | -1.61 % | $ 425 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.37 | -1.8 % | $ 411 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
-1.8 | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
Personalis
PSNL
|
-7.07 | $ 7.51 | -1.38 % | $ 445 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
RadNet
RDNT
|
17.6 | $ 59.53 | -3.58 % | $ 4.48 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 157.49 | -0.32 % | $ 7.81 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 164.98 | -1.19 % | $ 28.4 B | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.58 | -0.6 % | $ 275 M | ||
|
Sotera Health Company
SHC
|
24.8 | $ 13.78 | -0.76 % | $ 3.91 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.21 | -17.47 % | $ 6.59 M | ||
|
National Research Corporation
NRC
|
21 | $ 17.47 | -0.26 % | $ 391 M | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.54 | -4.06 % | $ 102 M | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 572.18 | -1.09 % | $ 46 B | ||
|
Illumina
ILMN
|
70.5 | $ 124.58 | 0.64 % | $ 19.8 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 99.8 | -0.55 % | $ 8.23 B | ||
|
Guardant Health
GH
|
-28.8 | $ 82.96 | -2.36 % | $ 10.4 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 44.3 | -0.45 % | $ 2.65 B | ||
|
Celcuity
CELC
|
-2.38 | $ 100.81 | -5.57 % | $ 3.98 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 263.8 | -0.23 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 7.9 | -2.47 % | $ 1.01 B | ||
|
Natera
NTRA
|
-19.5 | $ 194.02 | -3.03 % | $ 19.1 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.35 | -1.2 % | $ 925 M | ||
|
OPKO Health
OPK
|
25.9 | $ 1.14 | -1.3 % | $ 791 M |